Zobrazeno 1 - 10
of 36
pro vyhledávání: '"J.-C. Crave"'
Autor:
M. Michallet, Isabelle Marie, J. Dantal, J.-C. Delain, P. Chérin, Jean-François Viallard, E. Pelus, J.-C. Crave
Publikováno v:
La Revue de Médecine Interne. 38:312-319
Both intravenous and subcutaneous immunoglobulins are therapeutic modalities approved in various conditions, including primary and secondary immune deficiencies and autoimmune disorders. To date, immunoglobulins have more often been considered as a s
Autor:
Nicolas Mayeur, J.-F. Charbonnel, C. Cornillot, A. Aouifi, J.-C. Crave, Marie Pasquie, E. Lapeyre, Hélène Charbonneau, A. Martel, V. Frebault
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 34:S44-S45
Introduction Fresh Frozen Plasma (FFP) is used to correct haemostatic function after cardiac surgery with cardio-pulmonary bypass (CPB). As a blood product, availability of FFP can be challenging. OctaplasLG®, a solvent/detergent (SD) treated and po
Autor:
M. Pasquet, J. C. Crave, G. Cozon, Eric Hachulla, R. Jaussaud, B. Bienvenu, C. Hoarau, P. Cherin, Pierre Clerson, J.-C. Delain
Publikováno v:
Orphanet Journal of Rare Diseases
Background IgG replacement therapy (IgRT) in primary immunodeficiencies (PID) is a lifelong treatment which may be administered intravenously (IVIg) or subcutaneously (SCIg), at hospital or at home. The objective of the VISAGE study was to investigat
Autor:
I, Marie, P, Chérin, M, Michallet, E, Pelus, J, Dantal, J-C, Crave, J-C, Delain, J-F, Viallard
Publikováno v:
La Revue de medecine interne. 38(5)
Both intravenous and subcutaneous immunoglobulins are therapeutic modalities approved in various conditions, including primary and secondary immune deficiencies and autoimmune disorders. To date, immunoglobulins have more often been considered as a s
Autor:
J.-C. Crave, O. Benbrahim, S. Choquet, Bruno Royer, Pierre Clerson, V. Lévy, J.-C. Delain, Jean-François Viallard
Publikováno v:
La Revue de Médecine Interne. 37:A107-A108
Introduction Les hemopathies malignes sont frequemment associees a un deficit immunitaire secondaire responsable d’infections aggravant leur pronostic. Le deficit immunitaire secondaire peut etre cause par l’hemopathie maligne, ou etre induit ou
Autor:
N. Berger-Dutrieux, M. Devonec, Hervé Lejeune, J C Crave, Philippe Durand, Rachel Levy, Michel Pugeat, C. Brébant, J.M. Saez
Publikováno v:
Andrologie. 6:370-373
Afin de mieux comprendre l'implication des facteurs de regulation de la spermatogenese en pathologie humaine, nous avons developpe une methode de mesure des ARN messagers (ARNm) par reverse transcription-polymerase chain reaction (RT-PCR), applicable
Autor:
J. C. Crave
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 80:2057-2062
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 80:2057-2062
Evidence suggests that hyperinsulinemic insulin resistance may increase serum levels of ovarian androgens and reduce sex hormone-binding globulin (SHBG) levels in humans. The present study was conducted to assess the effect of administration of the b
Autor:
Pierre Clerson, J.-C. Delain, Bruno Royer, S. Choquet, F. Viallard, J.-C. Crave, O. Benbrahim, V. Lévy
Publikováno v:
La Revue de Médecine Interne. 37:A108
Introduction Les hemopathies malignes sont frequemment associees a un deficit immunitaire secondaire, facteur majeur d’infections. Chez les patients presentant un deficit immunitaire secondaire avec hypogammaglobulinemie, une immunotherapie substit
Autor:
J. C. Crave
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 80:1283-1289